Motivational InterventionNCT07585838
Hope-Focused Motivational Interviewing in Cancer Patients
A study testing Hope-Focused Motivational Interviewing in people with Motivational Intervention and Cancer, run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).
Trial summary
This study aims to examine the effects of hope-focused motivational interviewing on levels of hope, self-efficacy, and self-compassion in patients with cancer receiving radiotherapy, using a randomized controlled design. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Motivational Intervention, Cancer, Hope
- What is being tested?
- Hope-Focused Motivational Interviewing
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 46 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 Jun 2026to 30 Dec 2026
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Being 18 years of age or older
- Having a diagnosis of Stage I-III cancer according to the TNM staging system Receiving radiotherapy at the study center (including adjuvant, neoadjuvant, or definitive RT)
- Being in the first week of the radiotherapy process
- Being able to read and understand Turkish and communicate at a level sufficient to participate in interviews
- Agreeing to attend the intervention sessions at scheduled times and providing written informed consent
Who cannot join
- Presence of metastatic disease (Stage IV) or recurrent cancer
- Receiving concurrent chemotherapy during the radiotherapy process
- Presence of severe psychiatric conditions that may interfere with participation or the safe implementation of the intervention (e.g., psychotic disorders, bipolar disorder in the manic phase, or severe major depression)
- Presence of moderate to severe cognitive impairment/dementia, significant attention or concentration problems, or neurological conditions that may compromise the reliability of responses
- Severe hearing or speech impairments or communication difficulties that would prevent participation in interviews or completion of questionnaires (if appropriate support cannot be provided)
- Participation in another structured psychosocial intervention program (e.g., hope-based, psychoeducational, or psychotherapeutic programs) during the study period
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Effects of Hope-Focused Motivational Interviewing on Hope, Self-Efficacy, and Self-Compassion in Cancer Patients Undergoing Radiotherapy: A Randomized Controlled Trial
This study aims to examine the effects of hope-focused motivational interviewing on levels of hope, self-efficacy, and self-compassion in patients with cancer receiving radiotherapy, using a randomized controlled design.
Read the detailed description
This study is designed as a randomized controlled experimental study with a pretest-posttest and follow-up design. It will be conducted with individuals diagnosed with cancer who are receiving inpatient care in the Radiation Oncology unit of a City Hospital. According to the G*Power analysis, a minimum of 46 participants (intervention = 23, control = 23) will be included in the study. The computer-aided https://www.random.org/integers/ program will be used to assign the intervention and control groups without bias. The intervention group will receive a "Hope-Focused Motivational Interviewing" program consisting of four sessions delivered twice weekly, while the control group will receive routine treatment and care. Data will be collected using the "Information Form," "Herth Hope Index," "Brief Self-Compassion Scale," and "General Self-Efficacy Scale." Measurements will be obtained before and after the intervention. To minimize bias, data will be collected via Google Forms. The first page of the form will include information about the study along with an informed consent statement, and participants will be required to provide their consent before proceeding. Participants who agree to take part in the study will complete the questionnaires within approximately 15-20 minutes.
- Conditions
- Motivational Intervention, Cancer, Hope, Self-Compassion, Self-Efficacy
- Being tested
- Hope-Focused Motivational Interviewing
- Keywords
- motivational ıntervention, cancer, hope, self-compassion, self-efficacy
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Hope-Focused Motivational InterviewingBehavioural
Participants in the intervention group will receive an individual-based Hope-Focused Motivational Interviewing program consisting of four sessions delivered twice weekly. Each session will last approximately 30-40 minutes. The program includes the following components: (1) exploration of hope and goal setting, (2) enhancement of self-efficacy, (3) development of self-compassion, and (4) coping with barriers and creating a sustainable coping plan. Assessments will be conducted at baseline (pre-test), post-intervention, and at 1-month follow-up.
| Study group | Role | What they receive |
|---|---|---|
| Experimental | Experimental | Participants in the intervention group will receive an individual-based Hope-Focused Motivational Interviewing program consisting of four sessions delivered twice weekly. Receives: Behavioral: Hope-Focused Motivational Interviewing |
| Control | No intervention | Participants in the control group will receive routine care only and will not be exposed to any structured psychosocial intervention during the study period. Data will be collected at the same time points as the intervention group (baseline, post-test, and 1-month follow-up). |
What is being measured
The primary outcome is the main question the study is designed to answer.
Herth Hope Index
The scale consists of 12 items and three subscales: (1) temporality and future, (2) positive readiness and expectancy, and (3) interconnectedness with self and others. Items are rated on a 4-point Likert scale ranging from 0 (strongly disagree) to 3 (strongly agree). The "temporality and future" subscale (items 1, 2, 6, and 11) assesses the temporal dimension of hope; the "positive readiness and expectancy" subscale (items 4, 7, 10, and 12) reflects the emotional-behavioral aspects of hope; and the "interconnectedness" subscale (items 3, 5, 8, and 9) measures relational and contextual aspects of hope. Items 3 and 6 are negatively worded and are reverse scored. The total scale score is obtained by summing responses to all items, while subscale scores are calculated by summing the corresponding items. Total scores range from 12 to 48, with higher scores indicating greater levels of hope.
Measured: Baseline, immediately after the 2-week intervention, and 1 month post-intervention
Secondary outcomes (2)
Brief Self-Compassion Scale
The Brief Self-Compassion Scale consists of 12 items rated on a 5-point Likert scale. Items 1, 4, 8, 9, 11, and 12 are reverse scored. The scale comprises two factors: self-compassion and self-criticism (or maladaptive self-compassion). Total scores range from 12 to 60, with higher scores indicating greater levels of self-compassion.
Measured: Baseline, immediately after the 2-week intervention, and 1 month post-intervention
General Self-Efficacy Scale
The General Self-Efficacy Scale consists of 17 items rated on a 5-point Likert scale. Items 2, 4, 5, 6, 7, 10, 11, 12, 14, 16, and 17 are reverse scored. The scale includes three subscales: initiation, persistence, and maintenance effort. Total scores range from 17 to 85, with higher scores indicating higher levels of self-efficacy.
Measured: Baseline, immediately after the 2-week intervention, and 1 month post-intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 May 2026
- Study start15 Jun 2026 (estimated)
- Primary completion30 Oct 2026 (estimated)
- Study completion30 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Motivational InterventionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Intervention and control group
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 46 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Saglik Bilimleri Universitesi
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Duygu Özer, PhD, Bartın Unıversity
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07585838
- Sponsor's protocol ID
- BARU-SBF-DO-2
- Status last verified
- May 2026
- First submitted
- 2 May 2026
- Last updated
- 14 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No